
|Videos|October 25, 2013
Ovarian Cancer Maintenance Therapy With Bevacizumab
Author(s)Robert A. Burger, MD
Robert A. Burger, MD, Professor, Department of Surgical Oncology, Director, Women’s Cancer Center, Fox Chase Cancer Center, discusses ovarian cancer maintenance with bevacizumab.
Clinical Pearls
Robert A. Burger, MD, Professor, Department of Surgical Oncology, Director, Women’s Cancer Center, Fox Chase Cancer Center, discusses ovarian cancer maintenance with bevacizumab.
- In frontline trials, bevacizumab was administered with a maximum number of treatment cycles beyond chemotherapy
- In second-line trials, maintenance therapy was continued until disease progression



















